- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
MYL
Mylan N.V. Stock Is Headed Back Down to $40
Despite a wealth of bullish news since the beginning of March, MYL stock remains capped by this key trendline ... and it will send Mylan shares lower as a result.
3 Stocks to Watch on Friday: Novartis AG (ADR) (NVS), Nutanix Inc (NTNX) and Zumiez Inc. (ZUMZ)
Amazon (AMZN) explores online pharmaceuticals with Novartis AG (NVS), Nutanix (NTNX) and Zumiez (ZUMZ) report on their quarterly earnings.
Mylan N.V. Stock Moving on Q3 Profit Miss
Mylan (MYL) stock was on the move Monday following the release of its earnings report for the third quarter of the year.
Go Long Mylan N.V. After Earnings With Confidence
Biotech companies are still under threat from the White House. So I sell risk in Mylan for income into those fears. Bet on MYL stock support for cash.
Teva Pharmaceutical (TEVA) Stock Sinks on Lowered Outlook
Teva Pharmaceutical (TEVA) stock was down today after the company lowered its outlook for 2017 due to increasing competition.
Mylan N.V. (MYL) Stock Gets Massive Boost From Generic MS Drug Approval
Mylan (MYL) stock was flying high today on approval from the FDA for a generic version of Teva's (TEVA) MS drug Copaxone.
Mylan N.V. (MYL) to Pay $465M in EpiPen Settlement
Mylan N.V. (MYL) will pay $465 million to settle its EpiPen case, in which it misclassified the as a generic instead of a branded product.
Why Snap Inc (SNAP), J C Penney Company Inc (JCP) and Mylan N.V. (MYL) Are 3 of Today’s Worst Stocks
JCPenney (JCP), Snap (SNAP) and Mylan (MYL) shareholders couldn't wait for the trading week to come to a close.
Mylan N.V. (MYL) Stock Hit by Forecast Cut
Mylan (MYL) stock was down today after the company cut its forecast for the year and missed estimates for the second quarter of 2017.
Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence
Valeant Pharmaceuticals (VRX) finds relief as John Paulson joins the board, but what can he really do to help VRX stock holders?
Adamis Pharmaceuticals Corp (ADMP) Stock Up, Then Down on Allergy Med
Adamis Pharmaceuticals (ADMP) shares soared as the company unveiled a medication to treat allergies that serves as an EpiPen alternative.
Why Mylan N.V. (MYL), Cheesecake Factory Inc (CAKE) and Fossil Group Inc (FOSL) Are 3 of Today’s Worst Stocks
Mylan (MYL), Cheesecake Factory (CAKE) and Fossil Group (FOSL) couldn't win for losing on Tuesday. Here's what went wrong.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait
Teva Pharmaceutical (TEVA) is perhaps the poster child for what can go wrong with an investment. But TEVA stock is cheap and could double in price.
How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover
Teva Pharmaceutical desperately needs a new CEO - and a new strategy to boot - to stop the steady decline in TEVA stock.
Mylan NV (MYL) Ekes Out Q1 Earnings Beat Despite EpiPen Sales Decline
Drugmaker Mylan (MYL) got no help from EpiPen as it gave MYL stock holders a better-than-expected quarter.
“Haunted” Mylan N.V. (MYL) Stock Is Due for More Pain
Mylan (MYL) may have a nice track record of growth thanks to the EpiPen, but legal headwinds and general decency pose a significant threat to MYL stock.
